Jade Biosciences (JBIO) Other Non-Current Assets (2021 - 2026)

Jade Biosciences' (JBIO) quarterly Other Non-Current Assets came in at $69000.0 in Q1 2026, little changed on a QoQ basis from $69000.0 in Q4 2025.

Jade Biosciences (JBIO) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Jade Biosciences (JBIO) has 6 years of Other Non-Current Assets data on file, last reported at $69000.0 in Q1 2026.

Quarterly Other Non-Current Assets changed N/A year-over-year to $69000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69000.0 (changed N/A YoY) and the FY2025 annual result came in at $69000.0, down 97.81% from the prior year.
Other Non-Current Assets was little changed at $69000.0 in Q1 2026, from $69000.0 in the prior quarter.
In the past five years, Other Non-Current Assets ranged from a high of $3.1 million in Q4 2024 to a low of $60000.0 in Q2 2025.
A 5-year average of $1.3 million and a median of $903500.0 in 2022 frame the typical range for Other Non-Current Assets.
Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 747.68% — and 2025, when it slumped 97.81%.
Tracing JBIO's Other Non-Current Assets over 5 years: stood at $2.6 million in 2022, then decreased by 10.78% to $2.3 million in 2023, then jumped by 37.7% to $3.1 million in 2024, then tumbled by 97.81% to $69000.0 in 2025, then changed by 0.0% to $69000.0 in 2026.
The last three Other Non-Current Assets figures came in at $69000.0 (Q1 2026), $69000.0 (Q4 2025), and $174000.0 (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	2.31 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	124.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	42.45 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	109.58 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	18,237.65
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	62.96 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	65.13 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	104.44 Mn
10	Jade Biosciences	1.57 Bn	1.11 Bn	-	69,000.00

Download Data